Jun 22, 2011
Visit ASCO.org for complete information on the following:
- ASCO Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients with Advanced Non-small Cell Lung Cancer Considering First-line EGFR Tyrosine-kinase Inhibitor (TKI) Therapy (asco.org/pco/egfr)
- Coming in summer 2011: ASCO Guideline Update on Anti-emetics and a Focused Update of the 2009 ASCO Guideline Update on Chemotherapy for Stage IV Non-small Cell Lung Cancer (asco.org/guidelines)